The company expects 2025 organic revenue growth of 3%-7%, excluding the wind-down of certain product lines. GN Hearing anticipates 5%-9% growth, supported by new launches like ReSound Vivia and Savi.
The strides we've made in this field inspire hope for a future where hearing loss is not a barrier but a challenge we can ...
The FDA regulates what can and can't be called a hearing aid, but that doesn't mean your Samsung Galaxy Buds won't work as a ...
Hearing implants, such as cochlear implants through UCHealth and Cochlear Osia by Cochlear Americas, can help address ...
In a significant advancement in hearing and vision solutions, EssilorLuxottica has announced that its Nuance Audio Glasses ...